2022
DOI: 10.3390/biom12101344
|View full text |Cite
|
Sign up to set email alerts
|

From Small Peptides to Large Proteins against Alzheimer’sDisease

Abstract: Alzheimer’s disease (AD) is the most common neurodegenerative disorder in the elderly. The two cardinal neuropathological hallmarks of AD are the senile plaques, which are extracellular deposits mainly constituted by beta-amyloids, and neurofibrillary tangles formed by abnormally phosphorylated Tau (p-Tau) located in the cytoplasm of neurons. Although the research has made relevant progress in the management of the disease, the treatment is still lacking. Only symptomatic medications exist for the disease, and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 221 publications
0
2
0
Order By: Relevance
“…Among them, Alzheimer’s disease (AD) is characterized by the accumulation of amyloid-β and tau aggregates in the brain of patients . Although the exact cause of AD remains unknown, inhibiting tau aggregation is a potential therapeutic strategy. So far, various molecules have been tested for their potency to inhibit tau aggregation, including natural products. …”
Section: Introductionmentioning
confidence: 99%
“…Among them, Alzheimer’s disease (AD) is characterized by the accumulation of amyloid-β and tau aggregates in the brain of patients . Although the exact cause of AD remains unknown, inhibiting tau aggregation is a potential therapeutic strategy. So far, various molecules have been tested for their potency to inhibit tau aggregation, including natural products. …”
Section: Introductionmentioning
confidence: 99%
“…Significant examples are found in the literature, illustrating important and innovative chemical-biological studies. They include small peptides and large protein effects in Alzheimer's disease (Picone et al, 2022), emergence of bimolecular condensates as attractive targets for drug discovery (Mitrea…”
mentioning
confidence: 99%